Bayer Pharmaceuticals' chief operating officer said the head of the top U.S. drug regulator recently reassured industry ...

Bayer AG BAYRY recently announced that ... or preserved LVEF (HFpEF). With the FDA granting a priority review to the sNDA, a decision from the regulatory body is expected in the third quarter ...

Bayer has won U.S. Food and Drug Administration priority review for its application seeking expanded approval of its kidney-disease drug Kerendia in certain people with heart failure. Bayer on ...

Drug regulators said an experimental stroke preventer from Bayer and Johnson & Johnson is ... privately held Boehringer Ingelheim. The FDA review appeared to be good news for a rival treatment ...

Bayer subsidiary BlueRock Therapeutics has been granted a fast-track review by the FDA for DA01, its stem cell-based therapy for Parkinson's disease which is currently in early-stage clinical testing.

Bayer Healthcare's pulmonary hypertension drug, riociguat, has received a favourable review ahead of the US FDA's Cardiovascular and Renal Drugs Advisory Committee meeting today (6th August).

If the FDA follows through on the panel’s recommendations, Johnson & Johnson, Bayer and other drugmakers ... which are not under review. This week’s two-day meeting was prompted by researchers ...

FRANKFURT, March 4 (Reuters) - Bayer (BAYGn.DE), opens new tab said on Monday it acquired the exclusive marketing rights for Europe for a new drug that is under regulatory review to treat a rare ...

If the FDA follows through on the panel’s recommendations, Johnson & Johnson, Bayer and other drugmakers ... which are not under review. Hay fever setting in? Here are the 20 worst cities ...